Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
18 February, 2019 01:43 IST
Shilpa Medicare gets EIR for both API facilities at Raichur
Source: IRIS | 11 Jul, 2018, 12.02PM
Comments  |  Post Comment

Shilpa Medicare has received EIR (Establishment Inspection Report) from USFDA to its two API manufacturing facilities located at Raichur, Karnataka.

The inspection was carried out between January 16-19, 2018. The inspection has now been closed by USFDA, which means that both the facilities have now clearance from the USFDA.

The stock had underperformed the market over the past one month till Jul. 10, 2018, falling 3.04% compared with the Sensex's 2.60% rise. It underperformed the market in past one quarter, declining 18.18% as against 6.96% rise in the Sensex.

Shares of the company gained Rs 34.35, or 8.82%, to trade at Rs 424.00. The total volume of shares traded was 56,094 at the BSE (11.48 a.m., Wednesday).





Shilpa Medicare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Lupin launches Clobazam oral suspension - 15-Feb-2019 16:37
Muthoot Finance to raise upto Rs 7.50 bn through NCDs - 14-Feb-2019 11:01
Zydus gets USFDA nod for Triamterene & Hydrochlorothiazide capsules - 13-Feb-2019 13:10
L&T Construction bags contract for construction of hospitals - 13-Feb-2019 11:56
Strides receives USFDA approval for Triamcinolone Acetonide cream - 13-Feb-2019 11:52
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer